Product ID:BELZONA 1221 (SUPER E-METAL) SOLIDIFIER, 1105/1321
MSDS Date:03/07/1998
FSC:NIIN:Submitter:N EN
Status Code:A
MSDS Number: CKYJR

BELZONA INC.

2000 N. W. 88 COURT
MIAMI, FL 33172
US

Emergency Phone: 800-424-9300/202-483-7616

Info Phone: 305-594-4994

Preparer: DR. W. R. ASHCROFT

Cage: 0PX05

BELZONA INC.

MIAMI, FL 33172 US

Telephone: 305-594-4994

Cage: 0PX05

TITANIUM DIOXIDE

CAS: 13463-67-7

RTECS: XR2275000

OSHA PEL 15 MG/M3

ACGIH TLV: 10 MG/M3

DGEBA-EPOXY RESIN

CAS: 25068-38-6

RTECS: CE6880000

HEXAMETHYLENE-DIISOCYANATE (HDI)

CAS: 822-06-0

RTECS: MO1740000

OSHA PEL 0.005 PPM

ACGIH TLV: 0.034 MG/M3

EPA Report Quantity: 1 LB

DOT Report Quantity: 1 LB

HOMOPOLYMER OF HDI

CAS: 28182-81-2

RTECS: NQ9170000

MODIFIED SILICA

CAS: 67762-90-7

OSHA PEL 6 MG/M3

ACGIH TLV: 10 MG/M3

LD50 LC50 Mixture:LD50 ORAL: 5,000 MG/KG DGEBA-EPOXY RESIN
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:ROUTE(S) OF ENTRY: SKIN CONTACT, SKIN
ABSORPTION, EYE CONTACT, INHALATION. PRIME HAZARD(S): RESPIRATORY
AND SKIN SENSITIZER. EFFECTS OF EXPOSURE: ACUTE: SKIN, EYE AND
RESPIRATORY TRACT IRRITATION. H ARMFUL BY INHALATION. CHRONIC:
CHEMICAL ASTHMA, SENSITIZATION AND DERMATITIS.
Explanation of Carcinogenicity:NO DATA IS AVAILABLE FOR THE MIXTURE,
HOWEVER, NONE OF THE INGREDIENTS ARE LISTED AS CARCINOGENS BY OSHA,
NTP, ACGIH OR IARC.
Medical Cond Aggravated by Exposure:SKIN, EYE AND RESPIRATORY
CONDITIONS.

First Aid:INHALATION: IF SYMPTOMS ARE EXPERIENCED, REMOVE SOURCE OF
CONTAMINATION AND/OR MOVE VICTIM TO FRESH AIR. IF RECOVERY IS
DELAYED OR THERE ARE SIGNS OF DISTRESS OBTAIN MEDICAL ATTENTION
IMMEDIATELY. EYE CONTACT: FLUSH EYES WITH WATER FOR 15 MINUTES.
SEEK MEDICAL ADVICE IF ANY IRRITATION PERSISTS. SKIN CONTACT:
IMMEDIATELY REMOVE EXCESS WITH A CLEAN CLOTH AND WASH SKIN
THOROUGHLY WITH SOAP AND WATER. IF IRRITATION OR INFLAMMATION
PERSISTS, SEEK MEDICAL ADVICE. INGESTION: IF SWALLOWED, DO NOT
INDUCE VOMITING. RINSE MOUTH WITH WATER & DRINK PLENTY OF WATER.
CALL TAMPA BAY REGIONAL POISON CENTER (80 0-282-3171) AND/OR SEEK
MEDICAL ADVICE.

Flash Point Method:SCC
Flash Point:>100.C, 212.F
Extinguishing Media:WATER FOG (NOT A DIRECT STREAM OF WATER), FOAM,
CARBON DIOXIDE, DRY CHEMICAL.
Fire Fighting Procedures:WEAR PROTECTIVE CLOTHING AND USE
SELF-CONTAINED BREATHING APPARATUS (NIOSH APPROVED - ) TO PROTECT
AGAINST INHALATION OF POISONOUS VAPORS AND OTHER
DECOMPOSITION/COMBUSTION PRODUCTS. FULL BUNKER GEAR SHOULD BE
WORN IN EXTREME CASES. USE SAND TO CONTAIN BURNING MATERIAL.
Unusual Fire/Explosion Hazard:DECOMPOSITION AND COMBUSTION PRODUCTS
MAY BE HAZARDOUS. OSHA FLAMMABILITY CLASS: NOT APPLICABLE.

Spill Release Procedures:ABSORB WITH A DRY INERT MATERIAL (E.G., SAND).
SWEEP UP, PLACE INTO SUITABLE LABELLED CONTAINERS, SEAL AND DISPOSE
OF PROPERLY. FLUSH AREA WITH DILUTE AMMONIUM HYDROXIDE OR
WATER-ALCOHOL MIXTURE.

Handling and Storage Precautions:HANDLING: AVOID BREATHING VAPORS AND
CONTACT WITH SKIN AND EYES. STORAGE: OVERHEATING MAY CAUSE
CONTAINERS TO RUPTURE. UNOPENED CONTAINERS SHOULD BE STORED UNDER
COOL, DRY CONDITIONS. CHECK ALL CONTA INERS FOR LEAKS AT REGULAR
INTERVALS AND BEFORE USE.

Respiratory Protection:WHERE MACHINING OR ABRADING OF CURED MATERIAL
LEADS TO PRODUCTION OF RESPIRABLE AND/OR NUISANCE DUST AN
APPROPRIATE NIOSH APPROVED RESPIRATOR SHOULD BE WORN. IN CONFINED
AREAS OR WHERE GOOD NATURAL/ME CHANICAL VENTILATION IS NOT
AVAILABLE LEADING TO A RISK OF EXCEEDING THE TLV'S INDICATED AN
APPROPRIATE NIOSH APPROVED RESPIRATOR SHOULD BE WORN.
Ventilation:WHERE ADEQUATE NATURAL VENTILATION IS NOT AVAILABLE,
PROVIDE SUITABLE LOCAL EXHAUST VENTILATION.
Protective Gloves:IMPERMEABLE GLOVES SUCH AS NEOPRENE, NITRILE OR PVC.
Eye Protection:ANSI APPROVED CHEMICAL SAFETY GOGGLES .
Other Protective Equipment:EYEWASH STATION AND DELUGE SHOWER MEETING
ANSI DESIGN CRITERIA . SUITABLE PROTECTIVE CLOTHING TO MINIMIZE
SKIN CONTACT. REMOVE CONTAMINATED CLOTHING AND WASH BEFORE REUSE.
Work Hygienic Practices:WASH HANDS WITH SOAP AND WATER AND USE HAND
CREAM. WHERE THERE IS RISK OF CONTAMINATION OF FOOTWEAR, SAFETY
BOOTS SHOULD BE WORN AND CLEANED THOROUGHLY BEFORE REUSE.
Supplemental Safety and Health
WHEN USING, DO NOT EAT, DRINK OR SMOKE. REMOVE CONTAMINATED CLOTHING
AND LAUNDER BEFORE REUSE. WASH HANDS WITH SOAP AND WATER AFTER
HANDLING THIS PRODUCT.

Boiling Pt:>200.C, 392.F
Vapor Pres:0.05 MM HG @ 25C
Vapor Density:HEAV AIR
Spec Gravity:1.21
Solubility in Water:REACTS
Appearance and Odor:OFF-WHITE PASTE WITH AMMONIACAL ODOR.
Percent Volatiles by Volume:1-5

Stability Indicator/Materials to Avoid:YES
WATER (CARBON DIOXIDE EVOLVED), STRONG OXIDIZERS, ALCOHOL OR AMINES.
Stability Condition to Avoid:NOT APPLICABLE.
Hazardous Decomposition Products:GASEOUS COMBINATIONS OF CARBON,
HYDROGEN, NITROGEN AND OXYGEN MAY OCCUR AT ELEVATED TEMPERATURES.
Conditions to Avoid Polymerization:WILL NOT OCCUR WHEN STORED AND USED
AS DIRECTED.

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE WITH LOCAL, STATE AND
FEDERAL REGULATIONS.

Toxicological Information:TITANIUM DIOXIDE: LD50: ORAL: N/A. DERMAL:
N/A. LC50: N/A. DGEBA-EPOXY RESIN: LD50: ORAL: 5000 MG/M3. DERMAL:
2000 MG/M3. LC50: N/A. HEXAMETHYLENE-DIISOCYANATE (HDI): LD50:
ORAL: 0.005 MG/M3. DERMAL : 0.034 MG/M4. LC50: N/A. HOMOPOLYMER OF
HDI: LD50: ORAL: N/A. DERMAL: N/A. LC50: N/A. MODIFIED SILICA:
LD50: ORAL: 5000 MG/M3. DERMAL: N/A. LC50: N/A.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

SARA Title III Information:NOTIFICATION OF TOXIC CHEMICALS: NONE OF THE
CONSTITUENTS OF THIS PRODUCT ARE SUBJECT TO REPORTING REQUIREMENTS
UNDER SECTION 313 OF THE SUPERFUND AMENDMENT AND REAUTHORIZATION
ACT OF 1986 (40 CFR PAR T 372).